In support of that, the specific cleavage of GRP78 in glioblastoma cells (U251 line) treated with the fusion protein epidermal growth factor (EGF)-SubA increased the cancer cell sensitivity to both temozolomide and ionizing radiation [245]. This evidence concerns the gene HSPA5 and cancer.